The rate as published in the Hospital Outpatient Prospective Payment System (HOPPS) as of January 2021 was $0.75 per millicurie, but the CMS has confirmed in a correction notice that the correct rate should be $626.58 per millicurie, according to the SNMMI. Any corrections will be retroactive to January 1, according to SNMMI.

The SNMMI has been teaming up with Zionexa to seek proper reimbursement for Cerianna, a radiolabeled F-18 fluoroestradiol radiotracer. Cerianna is indicated for use -- as an adjunct to biopsy -- with PET for detection of estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer.